Phase II study of FR901228 [romidepsin] in patients with refractory or progressive small cell or non-small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 15 Aug 2013
At a glance
- Drugs Romidepsin (Primary)
- Indications Non-small cell lung cancer; Small cell lung cancer
- Focus Therapeutic Use
- 31 May 2007 New trial record.